MSD has announced interim results of a trial involving anti-PD-1 antibody KEYTRUDA (pembrolizumab) for the treatment of bladder cancer. …
Latest Video
New Stories
-
James McDonnell: Industry 'on the cusp of something quite extraordinary'
September 20, 2019 - - Latest News -
iNova looking for local innovators
September 20, 2019 - - Latest News -
Not a great combination for the sector
September 20, 2019 - - Latest News -
Novartis provides updated data on gene therapy
September 20, 2019 - - Latest News -
Pharmaceutical spend down slightly on Budget forecast
September 19, 2019 - - Latest News -
New study finds link between gene mutation and disease
September 19, 2019 - - Latest News -
New deal for Australian cell therapy company
September 19, 2019 - - Latest News